|
Status |
Public on May 22, 2024 |
Title |
JEE037 |
Sample type |
genomic |
|
|
Source name |
Diagnostic Fresh Bone Marrow_MRDposDay15_MRDnegEndInduc
|
Organism |
Homo sapiens |
Characteristics |
tissue: Diagnostic Fresh Bone Marrow
|
Extracted molecule |
genomic DNA |
Extraction protocol |
DNA from MACS-sorted blasts were extracted using the Allprep mini kit and the robotic workstation QIAcube (Qiagen, Hilden, Germany) following the manufacturer's protocol
|
Label |
Cy5, Cy3
|
Label protocol |
Standard Illumina Protocol
|
|
|
Hybridization protocol |
Bisulfite-converted DNA was amplified and hybridized to the Infinium Methylation EPIC Kit chips
|
Scan protocol |
Illumina’s iScan
|
Description |
205657370130_R01C01
|
Data processing |
Low-confidence probes (p-value >0.05) and probes mapped to X and Y chromosomes were excluded from the analysis. Normalization was done using NOOB (background correction method with dye-bias normalization for Illumina Infinium methylation arrays).
|
|
|
Submission date |
Apr 05, 2023 |
Last update date |
May 22, 2024 |
Contact name |
Jovanny Zabaleta |
E-mail(s) |
jzabal@lsuhsc.edu
|
Phone |
504-210 2979
|
Organization name |
Louisiana State University Health Sciences Center
|
Department |
Cancer Center/Interdiscipliary Oncology
|
Lab |
LCRC 909
|
Street address |
1700 Tulane Ave.
|
City |
New Orleans |
State/province |
LA |
ZIP/Postal code |
70112 |
Country |
USA |
|
|
Platform ID |
GPL21145 |
Series (2) |
GSE229052 |
MIR4435-2HG as a novel predictive biomarker of chemotherapy response and death in pediatric B-cell ALL [methylation] |
GSE229056 |
MIR4435-2HG as a novel predictive biomarker of chemotherapy response and death in pediatric B-cell ALL |
|